Recurrent Cardiac Sarcoidosis After Heart Transplantation
The explanted heart should be extensively examined for CS in transplant recipients; if found, clinicians should prescribe CS-effective therapy indefinitely to prevent recurrence.
Authors
- Veli K. Topkara (ORCID: https://orcid.org/0000-0002-2236-2008)
- Molly Cole
- Nandakumar Menon (ORCID: https://orcid.org/0000-0001-8542-0028)
- D. Pham (ORCID: https://orcid.org/0000-0002-0212-9145)
- Jefree J. Schulte (ORCID: https://orcid.org/0000-0003-3920-0301)
- Carmen Sílvia Grubert Campbell (ORCID: https://orcid.org/0000-0001-5946-7180)
- Elise Strycharske
Institutions
- University of Wisconsin–Madison (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1016/j.jaccas.2025.105601
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00